Jpmorgan Chase & Co »

Kiniksa Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Kiniksa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiniksa Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiniksa Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $806k 46k 17.54
2023-09-30 $492k 28k 17.37
2023-06-30 $361k 26k 14.08
2023-03-31 $21k 1.7k 12.12
2022-12-31 $240k 20k 12.12
2022-06-30 $176k 18k 9.67
2022-03-31 $165k 18k 9.26
2021-12-31 $170k 14k 11.83
2021-03-31 $187k 10k 18.56
2020-12-31 $243k 12k 20.41
2020-09-30 $155k 10k 15.55
2020-06-30 $164k 6.4k 25.48
2020-03-31 $138k 8.9k 15.48
2019-12-31 $51k 4.6k 11.15
2019-09-30 $39k 4.6k 8.53
2019-06-30 $52k 3.8k 13.57
2019-03-31 $52k 2.9k 18.06
2018-12-31 $47k 1.7k 28.35
2018-09-30 $38k 1.5k 25.28